As we stand on the brink of a new era for immuno-oncology, the 3rd Spatial Biology for Immuno-Oncology Summit in January 2025 arrives at a pivotal moment for both pharma and biotech. The landscape of cancer treatment is rapidly evolving, fuelled by unprecedented advancements in spatial biology technologies that provide transformative insights into tumor-immune interactions. With the spatial biology market projected to reach $2.3 billion by 2029, and an estimated 500 patents filed across 195 companies, now is the time to leverage these innovations to refine discovery and clinical strategies that will significantly improve patient outcomes

Returning to San Diego in January 2025, the summit will showcase groundbreaking advancements and applications in spatial biology, emphasizing their role in revolutionizing immuno-oncology practices. As an attendee, you will gain insights into developing 'gold standard' methodologies that will enhance therapeutic strategies and patient care.